The Recall Desk
Agency classClass IIOur severity:HighFDA (Drugs)·D-0453-2026·Announced 2026-04-22

HydroPeptide Clear Alliance benzoyl peroxide serum recalled over benzene contamination

HydroPeptide Clear Alliance Serum, a 2.5% benzoyl peroxide product, is being recalled because of chemical contamination from the presence of benzene. 9,850 bottles are affected.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 3/5 (High).

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: FDA Class II recall for chemical contamination of a leave-on skin product, a risk of harm with no injuries reported in the source.

Plain-English summary

HydroPeptide Clear Alliance Serum, 2.5% benzoyl peroxide, sold in 1 fl oz (30 ml) and 2 fl oz (60 ml) spray bottles, is being recalled. The product is distributed by HydroPeptide LLC of Issaquah, Washington. The action covers 9,850 bottles.

The stated reason is chemical contamination through the presence of benzene. The FDA classified the action as Class II.

Affected lots are 2518800 (expiry 4/30/2027) and 2518900 (expiry 4/1/2027). Distribution was US nationwide.

Consumers who have an affected lot should stop using the product and contact the retailer or the firm about a refund. Anyone with health concerns after using it should speak to a healthcare professional.

The recalled product

Product
HydroPeptide CLEAR ALLIANCE SERUM, 2.5% BENZOYL PEROXIDE, a)1 FL OZ/30ml; b) 2 FL OZ/60ml spray bottle; DIST BY HYDROPEPTIDE LLC, ISSAQUAH, WA 98027
Manufacturer
Owen Biosciences Inc.
Category
Drug — Topical acne treatment
Hazard
Affected units
9,850

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • Lot# 2518800
  • Exp.: 4/30/2027 Lot# 2518900
  • Exp.: 4/1/2027

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 4 recalled by Owen Biosciences Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 4 products in this recall →

Related recalls

Same manufacturer · Owen Biosciences Inc.

See all →

Same hazard · chemical contamination

See all →

Similar recalls